Savara Inc
Clinical-stage biopharma developing inhaled therapies for rare respiratory diseases.
SVRA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US8051111016
- LEI:
- Country:
- United States of America
- Address:
- 6836 BEE CAVE ROAD, 78746 AUSTIN
- Website:
- https://savarapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Savara Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). This therapy, with the conditionally accepted trade name MOLBREEVI, is in Phase 3 clinical development for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung disease. Savara's strategy is centered on addressing the significant unmet medical needs of patients with severe and life-threatening orphan respiratory conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Savara Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Savara Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Savara Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
